1. Home
  2. NSPR vs PARK Comparison

NSPR vs PARK Comparison

Compare NSPR & PARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.29

Market Cap

72.1M

Sector

Health Care

ML Signal

HOLD

PARK

Park Dental Partners Inc.

N/A

Current Price

$17.75

Market Cap

67.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NSPR
PARK
Founded
2005
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Misc Health and Biotechnology Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.1M
67.4M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
NSPR
PARK
Price
$1.29
$17.75
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
42.4K
21.5K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,310,000.00
N/A
Revenue This Year
$57.98
$7.06
Revenue Next Year
$95.41
$6.17
P/E Ratio
N/A
$6.47
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$12.29
52 Week High
$2.93
$21.60

Technical Indicators

Market Signals
Indicator
NSPR
PARK
Relative Strength Index (RSI) 26.71 49.97
Support Level N/A $14.98
Resistance Level $2.50 $17.69
Average True Range (ATR) 0.12 1.16
MACD -0.04 0.17
Stochastic Oscillator 6.36 53.35

Price Performance

Historical Comparison
NSPR
PARK

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About PARK Park Dental Partners Inc.

Park Dental Partners Inc is a dental resource organization (DRO) operating through its subsidiary. It Provides comprehensive business support services including clinical team members, administrative personnel, facilities and equipment to its affiliated general and multi-specialty dental practices throughout Minnesota and Wisconsin. Its network of affiliated dental practices provides both general and specialty dental services, including oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics, under long-term agreements with initial terms of 30-years, with automatic 5-year renewals.

Share on Social Networks: